World J Mens Health.
2021 Apr;39(2):389-390. 10.5534/wjmh.200138.
Bone Health Risks Associated with Finasteride and Dutasteride Long-Term Use
- Sirufo MM
1,2 - Ginaldi L1,2
- Martinis MD1,2
- Affiliations
-
- 1Department of Life, Health and Environmental Sciences, University of L’Aquila, L’Aquila
- 2Allergy and Clinical Immunology Unit, Center for the Diagnosis and Treatment of Osteoporosis, AUSL Teramo, Italy
- KMID: 2513986
- DOI: http://doi.org/10.5534/wjmh.200138
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- A Case of Combination Therapy with Finasteride and Low Dose Dutasteride in the Treatment of Androgenetic Alopecia
- Health Risks Associated with Long-Term Finasteride and Dutasteride Use: It’s Time to Sound the Alarm
- The Different Reduction Rate of Prostate-Specific Antigen in Dutasteride and Finasteride
- Long-Term Effectiveness and Safety of Dutasteride versus Finasteride in Patients with Male Androgenic Alopecia in South Korea: A Multicentre Chart Review Study
- Retrospective Pharmacotherapeutic Evaluation of Dutasteride not Approved by US FDA for Androgenetic Alopecia in Korea
